MeiraGTx : Ph1/2 AAV5-RPGR (Botaretigene Sparoparvovec) Gene Therapy Trial in RPGR-associated X-linked Retinitis Pigmentosa (XLRP) Presentation

(marketscreener.com) Ph1/2 AAV5-RPGR (Botaretigene Sparoparvovec) Gene Therapy Trial in RPGR-associatedX-linked Retinitis Pigmentosa Michel Michaelides,1,* Cagri G. Besirli,2,† Yesa Yang,1 Sui Chien Wong,3 Jose Sahel,4 Syed...https://www.marketscreener.com/quote/stock/MEIRAGTX-HOLDINGS-PLC-44154954/news/MeiraGTx-Ph1-2-AAV5-RPGR-Botaretigene-Sparoparvovec-Gene-Therapy-Trial-in-RPGR-associated-X-link-41905067/?utm_medium=RSS&utm_content=20221001